A network meta-analysis of endocrine adverse events induced by immune checkpoint inhibitors in colorectal cancer
Immune checkpoint inhibitor (ICI) therapy for colorectal cancer (CRC) can be accompanied by endocrine adverse events, yet the comparative risk across commonly used regimens remains unclear. We therefore conducted a network meta-analysis of randomized c…